Dyne Therapeutics, Inc. ($DYN)
Filing Information
| Accession Number | 0001577014-26-000016 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 17, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
2,586,928
Total Value
$65,184,894.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 13, 2026 | Sale | 268,354 | $26.20 | $7,030,874.80 | 3,801,128 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Aug 13, 2026 | Sale | 94,415 | $26.20 | $2,473,673.00 | 1,045,735 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Aug 13, 2026 | Sale | 63,643 | $26.20 | $1,667,446.60 | 751,411 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Aug 14, 2026 | Sale | 1,359,674 | $25.00 | $33,991,850.00 | 2,441,454 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Aug 14, 2026 | Sale | 478,377 | $25.00 | $11,959,425.00 | 567,358 | Indirect | See footnote | View Details | |
Director | Common Stock | โ | Aug 14, 2026 | Sale | 322,465 | $25.00 | $8,061,625.00 | 428,946 | Indirect | See footnote | View Details |